Signature
Brenda K. Davis, Attorney-in-Fact
Issuer symbol
RYAM
Transactions as of
01 Mar 2026
Net transactions value
$0
Form type
4
Filing time
03 Mar 2026, 17:22:58 UTC
Previous filing
06 Mar 2025
Next filing
05 Mar 2026

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Ribeyrolle Christian Antoine Lucien SVP, Biomaterials 1301 RIVERPLACE BOULEVARD, SUITE 2300, JACKSONVILLE Brenda K. Davis, Attorney-in-Fact 03 Mar 2026 0001891056

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RYAM Common Stock Options Exercise $0 +8,940 +23% $0.000000 47,364 01 Mar 2026 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RYAM Restricted Stock Units Options Exercise $0 -8,940 -100% $0.000000 0 01 Mar 2026 Common Stock 8,940 Direct F2
transaction RYAM Restricted Stock Units Award $0 +9,504 $0.000000 9,504 01 Mar 2026 Common Stock 9,504 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction represents the conversion of 8,940 RSUs (Restricted Stock Units) into common stock, at a conversion price of $0.00 per share, in accordance with the terms of the RSU agreement. No monetary payment was made for the conversion.
F2 Each restricted stock unit represents a contingent right to receive one share of RYAM common stock.